Voyager Therapeutics, Inc. (VYGR) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -107.73M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-107.73M | (m) |
| 2026-03-31 | (m) | $-116.64M | (m) |
| 2025-12-31 | (m) | $-119.72M | (m) |
| 2025-09-30 | (m) | $-126.78M | (m) |
| 2025-06-30 | (m) | $-107.93M | (m) |
| 2025-03-31 | (m) | $-84.69M | (m) |
| 2024-12-31 | (m) | $-65.00M | (m) |
| 2024-09-30 | (m) | $25.88M | (m) |
| 2024-06-30 | (m) | $9.02M | (m) |
| 2024-03-31 | (m) | $-3.04M | (m) |
| 2023-12-31 | (m) | $132.33M | (m) |
| 2023-09-30 | (m) | $52.31M | (m) |
| 2023-06-30 | (m) | $95.83M | (m) |
| 2023-03-31 | (m) | $98.95M | (m) |
| 2022-12-31 | (m) | $-46.41M | (m) |
| 2022-09-30 | (m) | $-17.07M | (m) |
| 2022-06-30 | (m) | $-59.83M | (m) |
| 2022-03-31 | (m) | $-70.87M | (m) |
| 2021-12-31 | (m) | $-71.20M | (m) |
| 2021-09-30 | (m) | $-92.83M | (m) |
| 2021-06-30 | (m) | $17.92M | (m) |
| 2021-03-31 | (m) | $39.35M | (m) |
| 2020-12-31 | (m) | $36.74M | (m) |
| 2020-09-30 | (m) | $40.09M | (m) |
| 2020-06-30 | (m) | $-60.52M | (m) |
| 2020-03-31 | (m) | $-40.69M | (m) |
| 2019-12-31 | (m) | $-43.60M | (m) |
| 2019-09-30 | (m) | $-53.55M | (m) |
| 2019-06-30 | (m) | $-58.84M | (m) |
| 2019-03-31 | (m) | $-95.53M | (m) |
| 2018-12-31 | (m) | $-88.29M | (m) |
| 2018-09-30 | (m) | $-77.59M | (m) |
| 2018-06-30 | (m) | $-80.64M | (m) |
| 2018-03-31 | (m) | $-73.98M | (m) |
| 2017-12-31 | (m) | $-70.70M | (m) |
| 2017-09-30 | (m) | $-73.54M | (m) |
| 2017-06-30 | (m) | $-59.19M | (m) |
| 2017-03-31 | (m) | $-49.65M | (m) |
| 2016-12-31 | (m) | $-40.19M | (m) |
| 2016-09-30 | (m) | $-32.80M | (m) |
| 2016-06-30 | (m) | $-27.72M | (m) |
| 2016-03-31 | (m) | $-22.28M | (m) |
| 2015-12-31 | (m) | $-29.67M | (m) |
| 2015-09-30 | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) |
| 2014-12-31 | (m) | $-16.32M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |